MCID: ASP008
MIFTS: 46

Aspiration Pneumonitis

Categories: Respiratory diseases

Aliases & Classifications for Aspiration Pneumonitis

Summaries for Aspiration Pneumonitis

Disease Ontology : 12 A pneumonia that is defined as an acute lung injury after the inhalation of foreign material such as regurgitated acidic gastric contents, petroleum products and laxative oils. This syndrome occurs in patients who have a marked disturbance of consciousness such as that resulting from a drug overdose, seizures, a massive cerebrovascular accident, or the use of anesthesia. Aspiration of gastric contents results in a chemical burn of the tracheobronchial tree and pulmonary parenchyma, causing an intense parenchymal inflammatory reaction. The disease has symptom non-productive cough, has symptom tachypnea, has symptom bronchospasm, has symptom bloody sputum, has symptom frothy sputum, or has symptom respiratory distress, 2-5 hrs after aspiration.

MalaCards based summary : Aspiration Pneumonitis, also known as mendelson's syndrome resulting from a procedure, is related to aspiration pneumonia and lipid pneumonia, and has symptoms including respiratory distress, tachypnea and bronchospasm. An important gene associated with Aspiration Pneumonitis is HRH2 (Histamine Receptor H2), and among its related pathways/superpathways are Proton Pump Inhibitor Pathway, Pharmacodynamics and Secretion of Hydrochloric Acid in Parietal Cells. The drugs Fentanyl and Desflurane have been mentioned in the context of this disorder. Affiliated tissues include lung, liver and bone.

Related Diseases for Aspiration Pneumonitis

Diseases related to Aspiration Pneumonitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 79)
# Related Disease Score Top Affiliating Genes
1 aspiration pneumonia 32.2 ATP12A ATP4A
2 lipid pneumonia 11.3
3 pneumonia 10.2
4 peptic ulcer disease 10.0 ATP4A HRH2
5 fungal esophagitis 9.9 ATP12A ATP4A
6 diclofenac allergy 9.9 ATP12A ATP4A
7 gastroduodenal crohn's disease 9.9 ATP12A ATP4A
8 neonatal candidiasis 9.9 ATP12A ATP4A
9 photoallergic dermatitis 9.9 ATP12A ATP4A
10 squamous papillomatosis 9.9 ATP12A ATP4A
11 toxic megacolon 9.9 ATP12A ATP4A
12 gastrointestinal neuroendocrine benign tumor 9.9 ATP12A ATP4A
13 gastric antral vascular ectasia 9.9 ATP12A ATP4A
14 granulomatous gastritis 9.9 ATP12A ATP4A
15 esophageal candidiasis 9.9 ATP12A ATP4A
16 gastric neuroendocrine neoplasm 9.9 ATP12A ATP4A
17 acute laryngitis 9.9 ATP12A ATP4A
18 duodenitis 9.9 ATP12A ATP4A
19 rumination disorder 9.9 ATP12A ATP4A
20 congenital disorder of deglycosylation 9.9 ATP12A ATP4A
21 bladder calculus 9.9 ATP12A ATP4A
22 ischemic neuropathy 9.9 ATP12A ATP4A
23 bile reflux 9.9 ATP12A ATP4A
24 capillary disease 9.9 ATP12A ATP4A
25 dyskinesia of esophagus 9.8 ATP12A ATP4A
26 hernia, hiatus 9.8 ATP12A ATP4A
27 anismus 9.8 ATP12A ATP4A
28 postsurgical hypothyroidism 9.8 ATP12A ATP4A
29 lymphocytic colitis 9.8 ATP12A ATP4A
30 esophageal atresia/tracheoesophageal fistula 9.8 ATP12A ATP4A
31 clostridium difficile colitis 9.8 ATP12A ATP4A
32 diarrhea 1, secretory chloride, congenital 9.8 ATP12A ATP4A
33 esophagitis, eosinophilic, 1 9.8 ATP12A ATP4A
34 microscopic colitis 9.8 ATP12A ATP4A
35 laryngeal tuberculosis 9.8 ATP12A ATP4A
36 eosinophilic gastritis 9.8 ATP12A ATP4A
37 esophagus adenocarcinoma 9.8 ATP12A ATP4A
38 chronic intestinal vascular insufficiency 9.8 ATP12A ATP4A
39 polyposis, skin pigmentation, alopecia, and fingernail changes 9.8 ATP12A ATP4A
40 jejunoileitis 9.8 ATP12A ATP4A
41 pancreatic steatorrhea 9.8 ATP12A ATP4A
42 berylliosis 9.8
43 acute respiratory distress syndrome 9.8
44 esophageal varix 9.8 ATP12A ATP4A
45 superior mesenteric artery syndrome 9.8 ATP12A ATP4A
46 cleft palate, isolated 9.8
47 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.8
48 ocular motor apraxia 9.8
49 diabetes mellitus, ketosis-prone 9.8
50 bone fracture 9.8

Graphical network of the top 20 diseases related to Aspiration Pneumonitis:



Diseases related to Aspiration Pneumonitis

Symptoms & Phenotypes for Aspiration Pneumonitis

Symptoms:

12
  • respiratory distress
  • tachypnea
  • bronchospasm
  • non-productive cough
  • bloody sputum
  • frothy sputum

Drugs & Therapeutics for Aspiration Pneumonitis

Drugs for Aspiration Pneumonitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 190)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Not Applicable 437-38-7 3345
2
Desflurane Approved Phase 4 57041-67-5 42113
3
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
4
Remifentanil Approved Phase 4,Not Applicable 132875-61-7 60815
5
Chlorhexidine Approved, Vet_approved Phase 4,Not Applicable 55-56-1 2713 9552079
6
Ampicillin Approved, Vet_approved Phase 4,Phase 3 69-53-4 6249
7
Sulbactam Approved Phase 4,Phase 3 68373-14-8
8
Neostigmine Approved, Vet_approved Phase 4,Not Applicable 59-99-4 4456
9
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 5311068 68602
10
Lisinopril Approved, Investigational Phase 4 83915-83-7, 76547-98-3 5362119
11 Ramosetron Investigational Phase 4 132036-88-5
12 Chlorine dioxide Investigational Phase 4 10049-04-4
13 Bronchodilator Agents Phase 4,Phase 1,Not Applicable
14 Anesthetics Phase 4,Phase 3,Not Applicable
15 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Not Applicable
16 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3,Not Applicable
17 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Not Applicable
18 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1
19 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
20 Autonomic Agents Phase 4,Phase 1,Not Applicable
21 Protective Agents Phase 4,Phase 1
22 Cholinergic Antagonists Phase 4
23 Hypnotics and Sedatives Phase 4,Phase 3
24 Central Nervous System Depressants Phase 4,Phase 3,Not Applicable
25 Antiemetics Phase 4,Not Applicable
26 Anesthetics, General Phase 4,Phase 3
27 Anesthetics, Intravenous Phase 4,Phase 3
28 Anti-Infective Agents, Local Phase 4,Not Applicable
29 Chlorhexidine gluconate Phase 4,Not Applicable
30 Dermatologic Agents Phase 4,Phase 2,Phase 1,Early Phase 1,Not Applicable
31 Disinfectants Phase 4,Not Applicable
32 Adrenergic Agonists Phase 4,Not Applicable
33 Adrenergic alpha-Agonists Phase 4,Not Applicable
34 Adrenergic Agents Phase 4,Not Applicable
35 Cholinesterase Inhibitors Phase 4,Not Applicable
36 Cholinergic Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
37 HIV Protease Inhibitors Phase 4,Not Applicable
38
protease inhibitors Phase 4,Not Applicable
39 Neuromuscular Blocking Agents Phase 4,Not Applicable
40 Analgesics, Non-Narcotic Phase 4
41 Analgesics Phase 4
42 Adrenergic alpha-2 Receptor Agonists Phase 4
43 Adjuvants, Anesthesia Phase 4,Phase 3
44 Muscarinic Antagonists Phase 4
45
Glycopyrrolate Phase 4 596-51-0 3494
46 Cardiotonic Agents Phase 4
47 Angiotensin-Converting Enzyme Inhibitors Phase 4
48 Antihypertensive Agents Phase 4
49
Amoxicillin Approved, Vet_approved Phase 2, Phase 3 26787-78-0 33613
50
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757

Interventional clinical trials:

(show top 50) (show all 140)
# Name Status NCT ID Phase Drugs
1 Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications Completed NCT02644876 Phase 4 Penehyclidine inhalation;Placebo inhalation
2 The Effect of Total Intravenous Anesthesia With Propofol on Postoperative Nausea and Vomiting in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy Completed NCT01402622 Phase 4 Propofol anesthesia
3 Laryngoscope Versus CMAC for Endotracheal Intubation in Patients Undergoing Emergent Airway Management Completed NCT01710891 Phase 4
4 Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients Completed NCT00610324 Phase 4 Chlorhexidine gluconate;Potassium permanganate
5 Gastrostomy Tube Placed After Gastropexy Versus Gastrostomy Tube Placed Using the Traditional Push/Pull Techniques Completed NCT01463540 Phase 4
6 Effectiveness of a Chlorine Dioxide Spray on Dental Plaque and Respiratory Pathogens in Institutionalized Elders Completed NCT03533335 Phase 4
7 PROcalcitonin Pneumonia / Pneumonitis Associated With ASPIration Recruiting NCT02862314 Phase 4
8 Dexmedetomidine Versus Standard Clinical Practice During Non Invasive Mechanical Ventilation Recruiting NCT02958150 Phase 4 Dexmedetomidine
9 The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications Active, not recruiting NCT02861131 Phase 4 Sugammadex;Neostigmine
10 Avoiding Neuromuscular Blockers to Reduce Complications Not yet recruiting NCT03962725 Phase 4 Neuromuscular Blocking Agents;Anesthetic Adjuncts
11 Drug to Prevent Pneumonia in the Tube Fed Terminated NCT02358642 Phase 4 Angiotensin converting enzyme inhibitor (Lisinopril);Placebo
12 IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis Terminated NCT00774631 Phase 4
13 Pre Hospital Evaluation of Video Laryngoscopy Withdrawn NCT01374061 Phase 4
14 Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia Unknown status NCT01598402 Phase 2, Phase 3 amoxicillin/clavulanic acid suspension
15 SANICS II Trial: Stimulation of the Autonomic Nervous System in Colorectal Surgery by Perioperative Nutrition Unknown status NCT02175979 Phase 3
16 BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia Completed NCT01045902 Phase 3 Avelox (Moxifloxacin, BAY12-8039);Sulbactam/Ampicillin
17 Sellick Interest in Rapid Sequence Induction Completed NCT02080754 Phase 3
18 Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults Completed NCT02610868 Phase 3 MYOBLOC
19 Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in Japan Recruiting NCT03336645 Phase 3 SHP615
20 Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting Recruiting NCT03336450 Phase 3 SHP615;MHOS/SHP615
21 Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia Terminated NCT01971320 Phase 3
22 Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects Terminated NCT00000362 Phase 3
23 A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor Terminated NCT02377466 Phase 3 Retosiban IV infusion;Placebo IV infusion
24 A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour Terminated NCT02292771 Phase 3 Retosiban;Atosiban;Placebo matching retosiban;Placebo matching atosiban
25 Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After Pancreaticoduodenectomy Unknown status NCT01607307 Phase 2 Oral/enteral TJ-100 solution;Oral/enteral placebo solution
26 Reversal of the Neurological Deficit in Acute Stroke With the Signal of Efficacy Trial of Auto BPAP to Limit Damage From Suspected Sleep Apnea Unknown status NCT01812993 Phase 2
27 Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia Completed NCT01777672 Phase 2
28 Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging Completed NCT03050957 Phase 2
29 Cough and Swallow Rehab Following Stroke Completed NCT01907321 Phase 1, Phase 2 Measures performed on all subjects
30 Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts Completed NCT00773227 Phase 2
31 Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease Completed NCT01479127 Phase 2 ABT-SLV187;Oral Levodopa/Carbidopa
32 Dysport for the Treatment of OMD Completed NCT01921270 Phase 1, Phase 2 Low Dose - AbobotulinumtoxinA
33 Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial Recruiting NCT02927691 Phase 2
34 Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer Recruiting NCT03224000 Phase 2
35 Improving SWAllowing After Stroke With Transcranial Direct Current Stimulation Active, not recruiting NCT01758991 Phase 1, Phase 2
36 Proof of Concept (POC) in Patients With Ischaemic Stroke Terminated NCT01808261 Phase 2 GSK249320 100/mg;Placebo
37 GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals Unknown status NCT02584751 Phase 1 Omeprazole
38 Cough According to Stimulus Type in PD Completed NCT02390089 Phase 1 Capsaicin vapor
39 Fecal Microbiota Transplantation for Treatment of Refractory Graft Versus Host Disease-a Pilot Study Not yet recruiting NCT03549676 Phase 1
40 Dynamic Laryngotracheal Separation for Aspiration Suspended NCT00580346 Phase 1
41 Bronchial Alpha Amylase as a Marker for Early Aspiration Pneumonia in Therapeutic Hypothermia. Unknown status NCT03007862
42 Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation Unknown status NCT03108430
43 EtCO2 Monitoring in Acute Self-poisoning Unknown status NCT01800123
44 Pre-Procedural Fasting in Cardiac Intervention Unknown status NCT02562638 Not Applicable
45 Establish Quantitative Measurements of Laryngeal Sensorimotor Functions and Evaluating the Grade of Phonation and Swallowing Impairment Unknown status NCT02243722
46 Laparoscopy Heller Myotomy With Fundoplication Associated Versus Peroral Endoscopic Myotomy (POEM) Unknown status NCT02138643 Not Applicable
47 Ultrasound Assessment of Gastric Content Before Anesthesia for Appendectomy Unknown status NCT02983175 Not Applicable
48 Comparison of Ultrasound and Videofluoroscopic Imaging Techniques in Diagnosing Dysphagia in Stroke Patients Unknown status NCT01249300
49 Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy Unknown status NCT00536952 Early Phase 1 Pulmozyme;Placebo
50 Mechanical Ventilation During Cardiac Surgery Unknown status NCT02090205 Not Applicable

Search NIH Clinical Center for Aspiration Pneumonitis

Genetic Tests for Aspiration Pneumonitis

Anatomical Context for Aspiration Pneumonitis

MalaCards organs/tissues related to Aspiration Pneumonitis:

42
Lung, Liver, Bone, Tongue, Testes, Cortex, Heart

Publications for Aspiration Pneumonitis

Articles related to Aspiration Pneumonitis:

(show top 50) (show all 109)
# Title Authors Year
1
Prophylactic Antimicrobial Therapy for Acute Aspiration Pneumonitis. ( 29438467 )
2018
2
Resolution of Chronic Aspiration Pneumonitis Following Endoscopic Endonasal Repair of Spontaneous Cerebrospinal Fluid Fistula of the Skull Base. ( 27247911 )
2016
3
Antibiotics "just-in-case" in a patient with aspiration pneumonitis. ( 25665174 )
2015
4
Interventions at caesarean section for reducing the risk of aspiration pneumonitis. ( 24497372 )
2014
5
Aspiration pneumonitis due to povidone-iodine aspiration during a facial bone fracture reduction operation. ( 24621762 )
2014
6
Aspiration pneumonitis caused by polyethylene glycol-electrolyte solution treated with conservative management. ( 24955273 )
2014
7
The effects of α-tocopherol on oxidative damage and serum levels of Clara cell protein 16 in aspiration pneumonitis induced by bile acids. ( 23023024 )
2013
8
Benzodiazepines and pneumonia or aspiration pneumonitis. ( 23370439 )
2013
9
Targeting aspiration pneumonitis. ( 24195869 )
2013
10
Aspiration pneumonitis caused by delayed respiratory depression following intrathecal morphine administration. ( 22514783 )
2012
11
Analysis of the protective biochemical and pathologic effects of aminoguanidine on an experimental aspiration pneumonitis model induced by bile acids. ( 24653522 )
2012
12
The effect of a single bolus of exogenous surfactant on lung compliance persists until two weeks after treatment in a model of acid aspiration pneumonitis. ( 20674759 )
2011
13
Interventions at caesarean section for reducing the risk of aspiration pneumonitis. ( 21398110 )
2011
14
Diffraction enhanced imaging of a rat model of gastric acid aspiration pneumonitis. ( 21958600 )
2011
15
Delayed onset, protracted delirium and aspiration pneumonitis associated with a combination of clozapine and electroconvulsive therapy. ( 22021960 )
2011
16
Interventions at caesarean section for reducing the risk of aspiration pneumonitis. ( 20091567 )
2010
17
Comparative evaluation of Glasgow Coma Score and gag reflex in predicting aspiration pneumonitis in acute poisoning. ( 19327309 )
2009
18
Unrecognised aspiration pneumonitis during enteroscopy: two cases report. ( 19530596 )
2009
19
Diabetic ketoacidosis guidelines and protection from aspiration pneumonitis. ( 19709157 )
2009
20
Pneumonia versus aspiration pneumonitis. ( 20122001 )
2009
21
Aspiration pneumonitis requiring intubation after procedural sedation and analgesia: a case report. ( 17084944 )
2007
22
Hemodynamics in experimental gastric juice induced aspiration pneumonitis. ( 17160420 )
2007
23
The role of alveolar macrophages in the pathogenesis of aspiration pneumonitis. ( 17691026 )
2007
24
Aspiration pneumonitis and Newton's law of gravitation. ( 17920996 )
2007
25
Alveolar plasminogen activator inhibitor-1 predicts ARDS in aspiration pneumonitis. ( 16284739 )
2006
26
Incidence, risk factors, and outcome of aspiration pneumonitis in ICU overdose patients. ( 16826384 )
2006
27
Pneumonia versus aspiration pneumonitis in nursing home residents: prospective application of a clinical algorithm. ( 15877549 )
2005
28
Aspiration pneumonitis primes the host for an exaggerated inflammatory response during pneumonia. ( 16096455 )
2005
29
Aspiration pneumonitis in an overdose population: frequency, predictors, and outcomes. ( 14707564 )
2004
30
Pneumonia versus aspiration pneumonitis in nursing home residents: diagnosis and management. ( 12534840 )
2003
31
Aspiration pneumonitis and aspiration pneumonia. ( 11228282 )
2001
32
Aspiration pneumonitis following papain enzyme treatment for oesophageal meat impaction. ( 11485597 )
2001
33
The use of noninvasive ventilation in acute respiratory failure associated with oral contrast aspiration pneumonitis. ( 10813226 )
2000
34
The role of tumor necrosis factor-alpha in the pathogenesis of aspiration pneumonitis in rats. ( 10443613 )
1999
35
Prevention of aspiration pneumonitis in the obstetric patient. ( 9248519 )
1997
36
An audit of perioperative aspiration pneumonitis in gynaecological and obstetric patients. ( 8904254 )
1996
37
Anaesthesia and aspiration pneumonitis. ( 8974508 )
1996
38
Aspiration pneumonitis and the laryngeal mask airway. ( 8135416 )
1994
39
Intraoperative aspiration pneumonitis and the laryngeal mask airway. ( 8346858 )
1993
40
Sucralfate does not reduce the risk of acid aspiration pneumonitis. ( 8370300 )
1993
41
Use of corticosteroids for aspiration pneumonitis. ( 8419566 )
1993
42
PEEP is necessary for exogenous surfactant to reduce pulmonary edema in canine aspiration pneumonitis. ( 1399997 )
1992
43
Meconium aspiration pneumonitis and/or persistent fetal circulation. ( 1518716 )
1992
44
A comparison of omeprazole and ranitidine for prophylaxis against aspiration pneumonitis in emergency caesarean section. ( 1539776 )
1992
45
Vomiting and aspiration pneumonitis with the laryngeal mask airway. ( 1733537 )
1992
46
Aspiration pneumonitis: risk factors and management of the critically ill patient. ( 1980179 )
1990
47
Aspiration pneumonitis prophylaxis in obstetric anaesthesia: comparison of effervescent cimetidine-sodium citrate mixture and sodium citrate. ( 2334627 )
1990
48
Reducing the risk of aspiration pneumonitis. ( 2655299 )
1989
49
Single-dose intravenous H2 blocker prophylaxis against aspiration pneumonitis: assessment of drug concentration in gastric aspirate. ( 2773628 )
1989
50
Aspiration pneumonitis. Prevention and treatment. ( 2796910 )
1989

Variations for Aspiration Pneumonitis

Expression for Aspiration Pneumonitis

Search GEO for disease gene expression data for Aspiration Pneumonitis.

Pathways for Aspiration Pneumonitis

Pathways related to Aspiration Pneumonitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.62 ATP4A HRH2
2 9.32 ATP4A HRH2

GO Terms for Aspiration Pneumonitis

Biological processes related to Aspiration Pneumonitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 potassium ion transport GO:0006813 9.4 ATP12A ATP4A
2 potassium ion import across plasma membrane GO:1990573 9.37 ATP12A ATP4A
3 ATP hydrolysis coupled proton transport GO:0015991 9.32 ATP12A ATP4A
4 cellular sodium ion homeostasis GO:0006883 9.26 ATP12A ATP4A
5 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.16 ATP12A ATP4A
6 cellular potassium ion homeostasis GO:0030007 8.96 ATP12A ATP4A
7 sodium ion export across plasma membrane GO:0036376 8.62 ATP12A ATP4A

Molecular functions related to Aspiration Pneumonitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 8.96 ATP12A ATP4A
2 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP12A ATP4A

Sources for Aspiration Pneumonitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....